Search by Drug Name or NDC

    NDC 70710-1359-06 LACOSAMIDE 10 mg/mL Details

    LACOSAMIDE 10 mg/mL

    LACOSAMIDE is a INTRAVENOUS INJECTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Zydus Pharmaceuticals USA Inc.. The primary component is LACOSAMIDE.

    Product Information

    NDC 70710-1359
    Product ID 70710-1359_be197211-9535-43ec-af98-4318fee3eb82
    Associated GPIs
    GCN Sequence Number 064437
    GCN Sequence Number Description lacosamide VIAL 200MG/20ML INTRAVEN
    HIC3 H4B
    HIC3 Description ANTICONVULSANTS
    GCN 14344
    HICL Sequence Number 035872
    HICL Sequence Number Description LACOSAMIDE
    Brand/Generic Generic
    Proprietary Name LACOSAMIDE
    Proprietary Name Suffix n/a
    Non-Proprietary Name Lacosamide
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form INJECTION
    Route INTRAVENOUS
    Active Ingredient Strength 10
    Active Ingredient Units mg/mL
    Substance Name LACOSAMIDE
    Labeler Name Zydus Pharmaceuticals USA Inc.
    Pharmaceutical Class Decreased Central Nervous System Disorganized Electrical Activity [PE]
    DEA Schedule CV
    Marketing Category ANDA
    Application Number ANDA209465
    Listing Certified Through 2024-12-31

    Package

    NDC 70710-1359-06 (70710135906)

    NDC Package Code 70710-1359-6
    Billing NDC 70710135906
    Package 10 VIAL in 1 CARTON (70710-1359-6) / 20 mL in 1 VIAL (70710-1359-1)
    Marketing Start Date 2022-06-29
    NDC Exclude Flag N
    Pricing Information N/A